Convalescent plasma therapy in COVID-19
The coronavirus disease 2019 (COVID‐19) affected many people in a short time and 5-10% of them were severely affected by the disease. A variety of treatment methods have been developed for this rapidly spreading disease and vaccine studies have been initiated. One of these treatment methods is conva...
Main Authors: | Ayse Uysal, Mehmet Ali Erkurt, Irfan Kuku, Ahmet Sarici, Soykan Bicim, Emin Kaya, Ilhami Berber |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Turaz Bilim
2022-06-01
|
Series: | Medicine Science |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=124800 |
Similar Items
-
Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia
by: Emine Hidayet, et al.
Published: (2022-06-01) -
Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature
by: Sonia N. Whang, et al.
Published: (2022-08-01) -
Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study
by: Ahmet Omma, et al.
Published: (2021-12-01) -
Convalescent (Immune) Plasma Therapy with all Aspects: Yesterday, Today and COVID-19
by: Öner Özdemir, et al.
Published: (2020-06-01) -
Challenges in the collection of convalescent plasma for COVID-19 patients at a plasma therapy trial site
by: Nidhi Bhatnagar, et al.
Published: (2020-01-01)